Horseshit! He is creating a problem with legal drugs
AI Overview
There is
no evidence of a general street drug shortage related to Donald Trump or his policies. In fact, global cocaine production is at record highs, and while U.S. overdose deaths have decreased, supply reduction efforts have generally not been shown to create long-term shortages of illicit substances.
Key facts regarding the illicit drug supply in the U.S. include:
- Abundant Supply: Despite law enforcement efforts, the overall supply of illicit drugs like fentanyl, methamphetamine, and cocaine remains high, driven by powerful transnational criminal organizations and high profitability.
- Fentanyl Purity and Potency: The U.S. Drug Enforcement Administration (DEA) has noted a decrease in the purity and potentially lethal dose concentration of seized fentanyl pills and powder in FY 2025. However, this indicates a change in cartel operations (e.g., more domestic pill production) rather than a comprehensive shortage, and experts note that supply reduction alone has not been effective at curbing demand.
- Policy Focus: The Trump administration's approach has emphasized an enforcement-heavy, supply-side strategy focused on border interdiction and targeting cartels, rather than demand-reduction efforts. Experts argue that such an approach is often ineffective in the long term, as market forces lead traffickers to smuggle cheaper, more potent alternatives (like fentanyl).
- Pharmaceutical Shortages: The U.S. is currently experiencing a record number of shortages for legal, prescription medications due to manufacturing problems, supply chain disruptions, and regulatory issues. Proposed tariffs by the Trump administration on imported pharmaceuticals could exacerbate these specific, legal drug shortages.
The idea that political policies have caused a shortage of street drugs is not supported by current data on the illicit market.